E Fund Management Co., Ltd. Biogen Inc. Transaction History

E Fund Management Co., Ltd.

$1.93 Billion
Q3 2024

A detailed history of E Fund Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 8,061 shares of BIIB stock, worth $1.21 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

8,061

Previous 7,067 14.07%

Holding current value

$1.21 Million

Previous $1.64 Million 4.64%

% of portfolio

0.08%

Previous 0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $187,935 - $235,379	994 Added 14.07%	8,061 $1.56 Million
Q2 2024 Aug 12, 2024	BUY	$190.52 - $236.72 $549,459 - $682,700	2,884 Added 68.95%	7,067 $1.64 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $27,138 - $34,266	128 Added 3.16%	4,183 $901,000
Q4 2023 Feb 06, 2024	BUY	$222.59 - $267.94 $78,574 - $94,582	353 Added 9.54%	4,055 $1.05 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $159,579 - $180,110	630 Added 20.51%	3,702 $951,000
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $100,466 - $116,091	-365 Reduced 10.62%	3,072 $875,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $18,985 - $21,633	-74 Reduced 2.11%	3,437 $956,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $284,752 - $345,980	-1,128 Reduced 24.32%	3,511 $972,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $45,752 - $63,088	235 Added 5.34%	4,639 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $156,220 - $185,775	833 Added 23.33%	4,404 $898,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $114,324 - $144,042	590 Added 19.79%	3,571 $752,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $50,382 - $64,748	225 Added 8.16%	2,981 $715,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $26,601 - $34,690	94 Added 3.53%	2,756 $780,000
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $646,732 - $757,685	2,662 New	2,662 $744,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Biogen Inc. Transaction History